Please find attached outcome of Rights Issue Committee Meeting pertaining to allotment of 14,41,776 Equity shares.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sunshield Chemicals has completed its Rights Issue, which opened on September 30, 2025 and closed on October 24, 2025. The Rights Issue Committee approved the allotment of 14,41,776 fully paid-up equity shares at ₹901 per share (face value ₹10, premium ₹891). As a result, the company's paid-up equity share capital has increased from 73,53,060 shares (₹7.35 crore) to 87,94,836 shares (₹8.79 crore), a rise of nearly 19.6% in share count. The allotment was finalised in consultation with the Registrar (Bigshare Services) and approved by BSE, the designated stock exchange for the issue. Total capital raised is approximately ₹129.9 crore at the issue price.
Existing shareholders who did not subscribe to the rights entitlement will see their stake diluted by about 16.4%. The fresh capital can strengthen the company's balance sheet for growth or debt reduction, which could be positive in the medium term.